Clinical Trial Update: RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from Phase 1 and Phase 2 studies of everolimus (RAD001) for neurocognition in individuals with PTEN hamartoma tumor s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pten Hamartoma Tumor Syndrome

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Boston Children's Hospital | Conditions: PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-02-17